MONTIGNY LE BRETONNEUX, France — In order to meet the needs of its clients in Life Sciences and Research and thus strengthen its position as leader for the lysing and homogenization of biological samples on the international market, Bertin Technologies is taking an innovative step forward, launching a new state-of-the-art apparatus called Precellys® Evolution.

Precellys® Evolution will be available for purchase from 18 September 2014 onwards and will be launched via an international network of 75 distribution partners.

Dedicated to the highly demanding markets of forensic science, pharmaceutical R&D and even environmental or cosmetic analysis, the Precellys® range of equipment has won widespread global recognition from the scientific community as tools that are hard-wearing, efficient and ergonomic. To date, more than 750 official publications contain references to Precellys® equipment.

The strength of Precellys® Evolution lies in particular in its efficiency; in this respect it is far superior to manual grinding (mortar), to ultrasound treatment (sonication) and also to chemical lysis. The mechanical lysis performed by this new equipment is achieved by the action of beads and more importantly a “precessional” motion at speeds up to 10 000 revolutions per minute.

Bertin Technologies designed its first biological sample homogenizer in 2002, at the behest of Bio-Rad Laboratories, during the crisis period involving ESB. This new piece of equipment needed to be able to address key issues associated with the performance of analyses in BSL3 laboratories. On the basis of this development, the Precellys® range was born in 2004, a family that has steadily grown year after year, with the arrival of new equipment of varying capacities (e.g. Minilys®), additional options (Cryolys®) and special grinding kits for specific applications or sample types (lysing kits).

The new Precellys® Evolution benefits from a unique technology patented by Bertin, a technology that makes it possible to efficiently homogenize an even greater number of different sized tubes, from 0.5ml to 15ml. It guarantees identical homogenization in each of the 24 tubes.

Several scientific partners have participated in the validation of this new homogenizer, in particular the NIH in the USA, the biotechnology company Genclis in France and the Institut Pasteur in Paris, user of Precellys® 24 for over 5 years now.